IL158999A0 - New compounds useful in reflux disease - Google Patents
New compounds useful in reflux diseaseInfo
- Publication number
- IL158999A0 IL158999A0 IL15899902A IL15899902A IL158999A0 IL 158999 A0 IL158999 A0 IL 158999A0 IL 15899902 A IL15899902 A IL 15899902A IL 15899902 A IL15899902 A IL 15899902A IL 158999 A0 IL158999 A0 IL 158999A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds useful
- new compounds
- reflux disease
- reflux
- disease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C313/02—Sulfinic acids; Derivatives thereof
- C07C313/04—Sulfinic acids; Esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102056A SE0102056D0 (sv) | 2001-06-08 | 2001-06-08 | New Compounds |
| SE0104342A SE0104342D0 (sv) | 2001-12-20 | 2001-12-20 | New compounds |
| PCT/SE2002/001085 WO2002100823A1 (en) | 2001-06-08 | 2002-06-04 | New compounds useful in reflux disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL158999A0 true IL158999A0 (en) | 2004-05-12 |
Family
ID=26655485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15899902A IL158999A0 (en) | 2001-06-08 | 2002-06-04 | New compounds useful in reflux disease |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6919379B2 (xx) |
| EP (1) | EP1399419A1 (xx) |
| JP (1) | JP2004529982A (xx) |
| KR (1) | KR20040007658A (xx) |
| CN (1) | CN1514825A (xx) |
| AR (1) | AR033779A1 (xx) |
| AU (1) | AU2002309420C1 (xx) |
| BR (1) | BR0210153A (xx) |
| CA (1) | CA2448518A1 (xx) |
| IL (1) | IL158999A0 (xx) |
| MX (1) | MXPA03011193A (xx) |
| NO (1) | NO20035431D0 (xx) |
| NZ (1) | NZ529920A (xx) |
| WO (1) | WO2002100823A1 (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7566738B2 (en) * | 2004-11-03 | 2009-07-28 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use |
| US7494985B2 (en) | 2004-11-03 | 2009-02-24 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use |
| CA2586111A1 (en) * | 2004-11-12 | 2006-06-08 | Neurochem (International) Limited | Methods and fluorinated compositions for treating amyloid-related diseases |
| US20060160777A1 (en) * | 2004-12-27 | 2006-07-20 | Anders Lehmann | New use of GABAbeta receptor agonists |
| WO2006071186A1 (en) * | 2004-12-27 | 2006-07-06 | Astrazeneca Ab | Use of gabab receptor agonists |
| WO2008033572A1 (en) | 2006-09-15 | 2008-03-20 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| US20100317626A1 (en) * | 2007-07-25 | 2010-12-16 | Astrazeneca Ab | The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD |
| WO2011113904A1 (en) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| DE3326545A1 (de) * | 1983-07-22 | 1985-01-31 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| WO1987004077A1 (en) | 1986-01-03 | 1987-07-16 | The University Of Melbourne | Gastro-oesophageal reflux composition |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| GB8911017D0 (en) | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| FR2663934B1 (fr) * | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| US5214063A (en) * | 1990-06-27 | 1993-05-25 | Adir Et Compagnie | 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB9420784D0 (en) | 1994-10-14 | 1994-11-30 | Glaxo Group Ltd | Medicaments |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| SE9904508D0 (sv) * | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
-
2002
- 2002-05-28 AR ARP020101983A patent/AR033779A1/es not_active Application Discontinuation
- 2002-06-04 MX MXPA03011193A patent/MXPA03011193A/es active IP Right Grant
- 2002-06-04 WO PCT/SE2002/001085 patent/WO2002100823A1/en active IP Right Grant
- 2002-06-04 NZ NZ529920A patent/NZ529920A/en unknown
- 2002-06-04 JP JP2003503592A patent/JP2004529982A/ja active Pending
- 2002-06-04 CN CNA028114558A patent/CN1514825A/zh active Pending
- 2002-06-04 KR KR10-2003-7015969A patent/KR20040007658A/ko not_active Application Discontinuation
- 2002-06-04 IL IL15899902A patent/IL158999A0/xx unknown
- 2002-06-04 BR BR0210153-0A patent/BR0210153A/pt not_active IP Right Cessation
- 2002-06-04 AU AU2002309420A patent/AU2002309420C1/en not_active Ceased
- 2002-06-04 CA CA002448518A patent/CA2448518A1/en not_active Abandoned
- 2002-06-04 US US10/479,763 patent/US6919379B2/en not_active Expired - Fee Related
- 2002-06-04 EP EP02736400A patent/EP1399419A1/en not_active Withdrawn
-
2003
- 2003-12-05 NO NO20035431A patent/NO20035431D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ529920A (en) | 2005-08-26 |
| AU2002309420C1 (en) | 2008-05-29 |
| US20040152775A1 (en) | 2004-08-05 |
| CA2448518A1 (en) | 2002-12-19 |
| JP2004529982A (ja) | 2004-09-30 |
| US6919379B2 (en) | 2005-07-19 |
| KR20040007658A (ko) | 2004-01-24 |
| WO2002100823A1 (en) | 2002-12-19 |
| MXPA03011193A (es) | 2004-02-26 |
| AR033779A1 (es) | 2004-01-07 |
| NO20035431D0 (no) | 2003-12-05 |
| CN1514825A (zh) | 2004-07-21 |
| EP1399419A1 (en) | 2004-03-24 |
| BR0210153A (pt) | 2004-06-08 |
| AU2002309420B2 (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002349297A8 (en) | Statin-like compounds | |
| GB0101996D0 (en) | Organtic compounds | |
| HK1070071A1 (en) | New pyrimidine compounds | |
| GB0108475D0 (en) | New compounds | |
| IL158999A0 (en) | New compounds useful in reflux disease | |
| IL153176A0 (en) | New phenylpiperazines | |
| GB0129013D0 (en) | Compounds | |
| EP1458669A4 (en) | ACTIVE COMPOUNDS ON THE NEUROLOGICAL PLAN | |
| AU2002311711A1 (en) | New compounds useful in reflux disease | |
| PL364090A1 (en) | New benzylaminopyrimidines | |
| GB0126988D0 (en) | Disease model | |
| GB0104168D0 (en) | Disease model | |
| GB0119920D0 (en) | New use | |
| GB0105098D0 (en) | Compounds | |
| GB2425310B (en) | N-aryloxypropanolyl-N' -phenethyl-urea | |
| GB0102220D0 (en) | Databases | |
| UA4975S (uk) | Ліжко «анна-3» | |
| FI5027U1 (fi) | Yläpohjarakenne | |
| GB0103261D0 (en) | Inflammatory disease | |
| HUP0102279D0 (en) | New compounds | |
| GB0117780D0 (en) | New compounds | |
| GB0112394D0 (en) | Mat for beach | |
| AU145218S (en) | Sink mat | |
| GB0128670D0 (en) | Eezee Paver | |
| GB0114008D0 (en) | New therapautic use |